14h
GlobalData on MSNIncyte stock hit 11% despite paediatric dermatology trials hitting targetThe US company’s two simultaneous trials in HS saw more than 40% of patients on povorcitinib achieving a clinical response.
The Federal Reserve continued its easing cycle in Q4, yet higher-than-expected inflation in December led the Fed to signal a ...
At the height of the campaign, Ukrainian forces controlled some 500 square miles of Russian territory. Now they hold just a small sliver of land along the border. By Marc Santora The ...
"The first months of 2025 have shown increased investor focus on international investing, with developed markets strongly outperforming their U.S. counterparts," says Arne Noack, regional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results